The Global Fund for Women is the a non-profit foundation funding women's human rights initiatives. It was founded in 1987 by New Zealander Anne Firth Murray, and co-founded by Frances Kissling and Laura Lederer to fund women's initiatives around the world. It is headquartered in San Francisco, California. Wikipedia.
News Article | May 22, 2017
These chefs are known for getting creative in the kitchen, and they each developed a recipe that will be offered in the meal kits, weekly throughout June. Starting with Mario Batali's Spaghetti with Fresh Tomatoes, Chorizo, and Basil available in the box from June 3rd to 9th, home chefs will rightly feel like they are dining in one of Batali's Michelin-starred restaurants. The week of June 10th to 16th will have Emeril Lagasse's Herby Dijon Chicken Breasts with Zucchini and Red Potatoes, which will lead to Rachael Ray's Grilled Buffalo Chicken with Carrot-Celery Slaw and Mashed Taters, the following week of June 17th to 23rd. Lastly, Carla Hall's Summery Lemon Chicken with Tarragon Chimichurri will be available in the box from June 24th to 30th. Customers can select one chef ambassador recipe, plus two others, as part of their weekly HelloFresh delivery. "Spaghetti with chorizo and juicy fresh tomatoes is what I crave in the summer. It's quick, it's customizable and I love turning up the spice by adding extra jalapeños. The best part… when you order it during June, it's raising money and awareness to fight AIDS with (RED). Bring on the heat!," said chef Mario Batali. Deborah Dugan, CEO, (RED), said "We're thrilled to be teaming-up with HelloFresh this June to bring (RED) into kitchens across the country. There is so much that home cooks can do to support the AIDS fight, and what better place to start that conversation than with the delivery of these delicious (HELLOFRESH)RED meal-kits created by our hugely talented chef ambassadors, Mario Batali, Rachael Ray, Emeril Lagasse and Carla Hall." In addition to the $20 donation by HelloFresh for new subscribers, all customers will have an opportunity to donate directly via the HelloFresh website, with those donations being matched by The Gates Foundation, up to $75,000. All money raised will go to The Global Fund. Visit HelloFresh.com or RED.org for additional information, or learn more about (RED) on Facebook, Instagram and Twitter. About HelloFresh HelloFresh currently operates in the USA, the United Kingdom, the Netherlands, Australia, Germany, Belgium, Austria, Canada and Switzerland. HelloFresh delivered 23.9 million meals in the 3-month period up to 31 December 2016 to over 850,000 active subscribers. HelloFresh was founded in November 2011 and is based in Berlin. Additional offices are located in New York, London, Amsterdam, Zurich, Sydney and Toronto. HelloFresh was ranked as the fastest growing European company by the Financial Times based on revenue growth between 2012-2015. About (RED) ™ (RED) was founded in 2006 to engage businesses and people in the fight against AIDS. (RED) partners with the world's most iconic brands that contribute up to 50% of profits from (RED)-branded goods and services to the Global Fund. (RED) Proud Partners include: Apple, Bank of America, Beats by Dr. Dre, Belvedere, Claro, The Coca-Cola Company, GAP, MCM, Salesforce, SAP, Starbucks, Telcel. (RED) Special Edition partners include: aden+anais, Alessi, ALEX AND ANI, Andaz, Billecart-Salmon, Fatboy USA, Fully, Girl Skateboards, Le Creuset, Mophie, S'well and Vespa. To date, (RED) has generated more than $465 million for the Global Fund to fight AIDS, Tuberculosis and Malaria, to support HIV/AIDS grants in Ghana, Kenya, Lesotho, Rwanda, South Africa, Swaziland, Tanzania and Zambia. 100 percent of that money goes to work on the ground – no overhead is taken. Global Fund grants that (RED) supports have impacted more than 90 million people with prevention, treatment, counseling, HIV testing and care services. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/hellofresh-turns-red-in-june-2017-300461410.html
News Article | May 4, 2017
Today, Mosquito Joe and the United Nations Foundation’s Nothing But Nets campaign announced a new partnership to raise awareness and funds to fight malaria. Mosquito Joe locations across the country will engage customers to help raise funds and awareness about mosquito-borne illnesses and the importance of mosquito control. With each $10 customer donation to Nothing But Nets, an insecticide-treated bed net will be provided to a family in sub-Saharan Africa at risk of the disease and without the resources to stay protected. Mosquito Joe has set a launch goal of 500 nets, with a Corporate office match for every net donated by customers, totaling 1,000 nets or $10,000. As its presence grows across 32 states, Mosquito Joe provides exceptional pest control services in hundreds of communities across the country. By protecting families from fleas, ticks, and mosquitoes through its high-quality services, the brand is actively making outside fun again. And now, the brand is taking an even stronger stance against mosquitoes by launching this new partnership with Nothing But Nets. Nothing But Nets is the world’s largest grassroots campaign fighting malaria, which is caused by a single mosquito bite. Malaria is preventable and treatable – for many families, insecticide-treated bed nets are the most effective way to stay healthy and thrive. The campaign has raised over $60 million and delivered more than 10 million mosquito bed nets, as well as other malaria interventions and treatments through its UN partners, to protect refugees and vulnerable families around the world. “Mosquito Joe is not only committed to protecting the communities that we serve with our outdoor pest control services, but also giving back to those in need who suffer from mosquito-borne illnesses in countries that our services don’t reach,” said Mosquito Joe CEO Kevin Wilson. The Nothing But Nets campaign boasts hundreds of thousands of supporters – like Mosquito Joe and its customers – who all help to protect families from the threat of malaria. ”Every two minutes, a child dies from malaria,” said Margaret Reilly McDonnell, director of Nothing But Nets. “We are grateful for committed partners like Mosquito Joe who are helping us end this disease for good. Customers and others interested in supporting the matching challenge can visit http://www.NothingButNets.net/mosquitojoe for more information. Contacts Rachel Henderson Communications Manager, Nothing But Nets O: 202.739.2782 rhenderson(at)unfoundation.org About Nothing But Nets Nothing But Nets is the world’s largest grassroots campaign to save lives by preventing malaria, a disease which claims the life of a child every two minutes. Inspired by sports columnist Rick Reilly, hundreds of thousands of people have joined the campaign that was created by the United Nations Foundation in 2006. Nothing But Nets has raised over $60 million to help deliver ten million bed nets to families in need, along with other crucial malaria interventions. In addition to raising funds for its UN partners, Nothing But Nets raises awareness and voices to advocate for critical malaria funding for the U.S. President’s Malaria Initiative and The Global Fund to Fight AIDS, Tuberculosis and Malaria. It only costs $10 to help save lives from this deadly disease. Visit http://www.NothingButNets.net to defeat malaria. About The United Nations Foundation The United Nations Foundation builds public-private partnerships to address the world’s most pressing problems, and broadens support for the United Nations through advocacy and public outreach. Through innovative campaigns and initiatives, the Foundation connects people, ideas, and resources to help the UN solve global problems. The Foundation was created in 1998 as a U.S. public charity by entrepreneur and philanthropist Ted Turner and now is supported by global corporations, foundations, governments, and individuals. For more information, visit http://www.unfoundation.org. ABOUT MOSQUITO JOE Virginia Beach, VA-based Mosquito Joe provides mosquito control treatment to residential and commercial customers nationwide. Technicians are trained mosquito control experts dedicated to getting rid of mosquitoes so people can enjoy being outside again. While each Mosquito Joe is an independently owned franchise that offers customers reliable and effective service from a trusted community member, it is also backed by a national network of technical expertise. For more information or franchising opportunities, visit http://www.mosquitojoefranchise.com.
News Article | April 17, 2017
Next week, the United Nations Foundation’s Nothing But Nets campaign will bring together more than 125 advocates from 29 states for its annual Leadership Summit, a three-day event to train and mobilize the next generation of grassroots leaders in the fight against malaria. The Summit culminates on Capitol Hill for World Malaria Day, April 25, galvanizing policymakers to support U.S. funding for global malaria programs. In response to dramatic proposed funding cuts to foreign assistance programs and UN agencies engaged in life-saving work around the world, these champions will meet with their members of Congress to help ensure the U.S. does not back away from its commitments to the fight against malaria and maintains a strong relationship with the United Nations. UK television broadcaster and malaria survivor, Charlie Webster, along with refugee turned supermodel and philanthropist, Mari Malek, are among several Summit speakers who aim to inspire Nothing But Nets champions to use their voices in their communities to help ignite progress against this deadly disease. During the Summit, champions will learn the necessary skills to help build awareness about malaria and how to talk with their elected leaders about the importance of funding for the United Nations, the President’s Malaria Initiative, and The Global Fund to Fight AIDS, Tuberculosis and Malaria. Every two minutes, a child dies from malaria. Nothing But Nets is the world’s largest grassroots campaign fighting this disease caused by a single mosquito bite. The campaign has raised $60 million and delivered over ten million nets and other malaria interventions and treatment through its UN partners to protect refugees and vulnerable families. Since 2000, there has been incredible progress made to defeat the disease – more than 6.8 million lives have been saved, and child mortality rates have decreased 71% in sub-Saharan Africa. Media Opportunity: This event is open to the press. Please contact Rachel Henderson, Nothing But Nets Communications Manager, for credentials and speaker availability.
News Article | August 4, 2017
Hansen, One of the World's Most Successful Entrepreneurs Who is Not a Household Name, Will Offer Training Courses, Seminars and More Through his New Venture LOS ANGELES, CA / ACCESSWIRE / August 4, 2017 / Robin Roy Krigslund Hansen, a successful entrepreneur from Denmark, is pleased to announce the launch of his new global HENROY investment fund that offers an innovative twist. To learn more about Hansen and his new HENROY Investment Fund, please check out http://www.henroy.ch/. Described by a company spokesperson as "one of the world's most successful entrepreneurs that you have probably never heard of," Hansen is as eccentric as he is accomplished. "Although has established and run companies that have made millions, he has almost strategically avoided the press and media, except to appear on the Bravo reality TV show 'Below Deck,'" the spokesperson noted, adding that Hansen lives in Denmark, but owns companies around the world. Hansen was inspired to launch his own HENROY investment fund by his desire to help startups and entrepreneurs, as well as teach people about investing. His new venture HENROY Investment Fund offers training courses, seminars, webinars, and even one on one coaching to private individuals. In order for as many people as possible to take advantage of the new courses, they will be available in four languages. "Most investment funds just take your money and invest it for you. Robin's goal is to teach people the fundamentals of successful investing and create a community of people helping and investing together intelligently,” the spokesperson noted, adding that his new fund empowers people to learn about where they are putting their money and how to invest it wisely, and actually invest it themselves. As the spokesperson noted, Hansen definitely has the education, experience and successful resume to back up his new HENROY investment fund. He has written more than 300 articles about the subject, which he publishes on DayTraderLand.com. Hansen, who earned an MBA, has built more than 30 companies. In 2008 he founded GoSocial and became Facebook's largest advertising partner. "Today, GoSocial is a $50M a year performance marketing agency. In 2015 he lead the acquisition of e-mail software company PARProgram for $12 million, which he has already resold at a substantial profit," the spokesperson noted. Although Hansen describes himself as frugal, when it comes to charity, the spokesperson said, he's the first to give. This summer, he participated in the Gumball 3000 Riga to Mykonos; while he was there he donated more than 15K Pounds to the Gumball Foundation. "He has also donated to children's education and charities around the world," the spokesperson noted. About Robin Roy Krigslund Hansen and the HENROY Global Investment Fund: Robin Roy Krigslund Hansen, a Denmark-based entrepreneur who own companies around the world, recently launched his own investment fund to help startups and other entrepreneurs like him. The HENROY Global Investment Fund is offering courses taught in four languages; his goal is to teach people the fundamental skills needed to be a successful investor. For more information, please visit http://www.henroy.ch/.
News Article | July 25, 2017
CHICAGO--(BUSINESS WIRE)--PhysIQ, a leader in developing solutions that leverage artificial intelligence (AI) to empower digital health for ambulatory patient monitoring and clinical trial support, today announced the closure of $8 million Series B financing led by 4490 Ventures. Joining 4490 is the Global Health Sciences (GHS) Fund through Quark Venture Inc. and GF Securities, along with existing investor LionBird and others. Dan Malven, Managing Partner at 4490 Ventures, and Zafrira Avnur, PhD, Chief Scientific Officer at Quark Venture, have also both joined the PhysIQ Board of Directors. The financing will be used in support of the commercial launch of the physIQ VitaLink solution. The company’s solution collects continuous physiological patient data from wearable and implantable sensors and applies AI technology to transform this data into personalized patient insight. Healthcare providers, payers, pharmaceutical and medical device companies are leveraging the FDA-cleared personalized analytics to proactively manage at-risk ambulatory patients. Pharmaceutical and medical device manufacturers are also integrating VitaLink into their clinical trials in order to capitalize on new, “real world” data sets to validate the safety and efficacy of their products. “Market reception to our transformational VitaLink solution confirms we have entered a new era of health care…one where continuous real world data and personalized analytics are generating unprecedented patient insight. PhysIQ’s proprietary AI-enabled technology detects subtle, yet significant, changes in physiological parameters, thereby allowing healthcare enterprises to proactively manage patients to mitigate the costs associated with readmissions, inadequate therapies, non-adherent patients and other clinical events in commercial, government and clinical trial settings. As we scale to meet demand for our game-changing healthcare solution, we enthusiastically welcome our new financial partners 4490 Ventures and Quark Venture/GF Securities,” said Gary Conkright, physIQ CEO, Director and Founder. “The convergence of IT and medicine holds the promise to fundamentally change how clinicians diagnose, treat, prescribe, intervene and manage patient health. Converting continuous data into actionable insight is a foundational capability to the future of healthcare delivery,” added Malven. “The physIQ team is uniquely equipped to make that happen with their market leading cloud-based platform and personalized analytics technology, protected with over 100 issued patents, that they previously commercialized in other highly demanding industries.” “PhysIQ’s ability to detect changes from a patient’s personalized baseline is a game-changer for pharmaceutical and medical device companies seeking better approaches to validate the safety and efficacy of their products. As a fund that invests in breakthrough health science technology platforms that lead to transformational change, we are very excited about the opportunity presented by physIQ’s powerful technology,” added Karimah Es Sabar, Director of the GHS Fund and Chief Executive Officer of Quark Venture. Technology Platform to Realize the Power of Personalized Medicine The VitaLink end-to-end solution includes the physIQ software platform and AI analytics suite, third-party wearable biosensors, a mobile Android device for secure patient data transmission, and clinician user interface. As a data- and device-agnostic platform, it can accommodate any Bluetooth-enabled biosensor and has been engineered to be massively scalable and capable of continuously monitoring tens of thousands of patients at a time. The condition-agnostic personalized analytics solution is being studied and evaluated across multiple clinical use cases (e.g. post-acute skilled nursing, home health and clinical trials) and patient populations (e.g. heart failure, COPD, oncology and chronic pain). PhysIQ is a company dedicated to enabling proactive care delivery models through its Personalized Physiology Analytics (PPA) and highly scalable cloud-based platform. The FDA 510k-cleared data analytics platform is designed to process multiple vital signs from wearable sensors to create a personalized dynamic baseline for each individual. By mapping vital sign relationships this way, physIQ’s analytics detect subtle deviations that may be a precursor to disease exacerbation or change in health and warrant clinical attention. With applications in both healthcare delivery and clinical trial support, physIQ is transforming continuous physiological data into insight for providers, health systems, payers, and pharmaceutical and medical device companies. For more information, please visit www.physiq.com. 4490 Ventures is an early-stage venture capital firm that invests broadly across the software technology spectrum, including hardware-enabled software and information businesses. 4490 Ventures specializes in partnering with Midwest-based entrepreneurs focused on building billion-dollar enterprise value companies. For more information, please visit www.4490.ventures. Global Health Science Fund was jointly established by Quark Venture Inc. and GF Securities in late 2016. Global Health Science Fund is a health sciences venture fund that invests globally in a diversified portfolio of innovative biotechnology and health sciences companies who are addressing unmet medical needs through innovations in drug development, medical devices, health IT and emerging convergent technologies.
News Article | July 10, 2017
DENVER--(BUSINESS WIRE)--The Boards of Trustees (each, a “Board”) of Clough Global Dividend and Income Fund (GLV), Clough Global Equity Fund (GLQ) and Clough Global Opportunities Fund (GLO) (each, a “Fund” and collectively, the “Funds”) announced today that each Board has approved a discount management program, which includes a tender offer for the Funds and a managed distribution of 10%, as further described below. The Boards of Trustees of the Funds have approved cash tender offers for up to 37.5% of each of GLQ’s and GLO’s respective outstanding common shares of beneficial interest and up to 32.5% of GLV’s outstanding common shares of beneficial interest (with respect to each Fund, the “Shares”) at a price per Share equal to 98.5% of each Fund’s respective net asset value (“NAV”) per Share as of the business day immediately following the expiration date of the tender offers. The Funds will repurchase Shares tendered and accepted in the tender offers in exchange for cash. The respective Board of Trustees of each Fund believes the tender offer could benefit participating shareholders by providing liquidity at a price per Share that is higher than the market price of the Shares. The Boards of Trustees believe the tender offers could also benefit the Funds and their long-term shareholders because the tender offers would be conducted at a price per Share that would be accretive to NAV. The Funds will also commence a four year managed distribution program. Beginning in August, 2017, and continuing through July, 2019 (the “Initial Managed Distribution Period”), each Fund will pay monthly distributions (subject to certain limitations) in an annualized amount of not less than 10% of the respective Fund’s average monthly NAV. Each Fund will calculate the average NAV from the previous month by taking the simple average of the NAV of the Fund based on the number of business days in that month on which the NAV is calculated. The amount of the monthly distribution will be calculated as 10% of the previous month’s average NAV, divided by twelve. Following the Initial Managed Distribution Period, the Board of each Fund will review the current distribution amount in light of the current distribution rate of peer funds selected by the Board and will seek to pay a monthly distribution in an amount not less than the average monthly distribution rate of the peer group for an additional two year period. Robert Butler, Chairman of the Boards, said “We are very pleased to be implementing a discount management program that will provide our shareholders with liquidity but more importantly, with the 4-year commitment to a managed distribution program, we believe we are positioning the Funds for the future as attractive vehicles for investors who seek regular and predictable distributions.” Saba Capital Management, L.P. (collectively with certain of its affiliates, “Saba”) announced that, in connection with the Funds and their respective Boards agreeing to take the actions set forth in the respective Standstill Agreements discussed below, it has withdrawn its slate of nominees to serve as trustees of each Fund. It has also withdrawn the proposals for GLV and GLO seeking a shareholder vote regarding the classified board structure of the Funds. The commencement of the tender offers and managed distribution program is pursuant to separate agreements (the “Standstill Agreements”) between each Fund and Saba. Subject to the terms of the Standstill Agreements and in consideration for the tender offers, managed distribution plan and other factors set forth in the Standstill Agreements, Saba has agreed, subject to the terms of the Standstill Agreements, to (1) tender all Shares of the Funds owned by it in the tender offers, (2) be bound by certain “standstill” covenants through July 10, 2021 and (3) vote its remaining Shares on all proposals submitted to shareholders in accordance with the recommendation of management through July 10, 2021. Additionally, each Fund has agreed to a four year managed distribution program as described above. The Funds have been advised that Saba will file a copy of each Fund’s Standstill Agreement with the U.S. Securities and Exchange Commission as an exhibit to its Schedule 13D. The Funds have not commenced the tender offers described in this release or declared any dividend or distribution. This announcement is not a recommendation, an offer to purchase or a solicitation of an offer to sell shares of any Fund and the above statements are not intended to constitute an offer to participate in any tender offer. Information about each tender offer, including its commencement, will be provided by future public announcements. Shareholders will be notified in accordance with the requirements of the Securities Exchange Act of 1934, as amended, and the Investment Company Act of 1940, as amended, either by publication or mailing or both. Each tender offer will be made only by an Offer to Purchase, a related Letter of Transmittal and other documents, to be filed with the SEC. Shareholders of the Funds should read the Offer to Purchase and tender offer statement and related exhibits when those documents are filed and become available, as they will contain important information about the applicable tender offer. These and other filed documents will be available to investors for free both at the website of the SEC and from the Funds. The Fund is a closed-end fund utilizing the Adviser’s research-driven, thematic process, with an investment objective of providing a high level of total return. Having a global, flexible mandate and exploiting the Firm’s research offices in Boston, the Fund will invest at least 80% in equity and equity-related securities in both U.S. and non-U.S. markets, and the remainder in fixed income securities, including corporate and sovereign debt, in both U.S. and non-U.S. markets. More information on the Clough Global Equity Fund, including the Fund’s dividend reinvestment plan, can be found at www.cloughglobal.com or call 877-256-8445. The Fund is a closed-end fund with an investment objective of providing a high level of total return. The Fund seeks to achieve this objective by applying a fundamental research-driven investment process and will invest in equity and equity-related securities as well as fixed income securities, including both corporate and sovereign debt. Utilizing the Adviser’s global research capabilities, with offices in Boston, the Clough Global Opportunities Fund will invest in both U.S. and non-U.S. markets. More information on the Clough Global Opportunities Fund, including the Fund’s dividend reinvestment plan, can be found at www.cloughglobal.com or call 877-256-8445. The Fund is a closed-end fund with an investment objective of providing a high level of total return. With analysts in Boston, the Clough Global Dividend and Income Fund seeks to pursue this objective by applying a fundamental research-driven investment process and will invest in equity and equity-related securities as well as fixed income securities, including both corporate and sovereign debt, in both U.S. and non-U.S. markets. More information on the Clough Global Dividend and Income Fund, including the Fund’s dividend reinvestment plan, can be found at www.cloughglobal.com or call 877-256-8445. Clough Capital is a Boston-based investment advisory firm which manages approximately $2.7 billion in assets: $1.1 billion in hedge fund and institutional accounts; $78 million in open-end mutual funds; and $1.5 billion in three closed-end funds (as of May 31, 2017) – Clough Global Dividend and Income Fund (GLV), Clough Global Equity (GLQ), and the Clough Global Opportunities Fund (GLO). The firm uses a global and theme-based approach and invests in securities on a global basis. An investor should consider investment objectives, risks, charges and expenses carefully before investing. To obtain a prospectus, annual report or semi-annual report which contains this and other information visit www.cloughglobal.com or call 877-256-8445. Read them carefully before investing. Each Fund is a closed-end fund and closed-end funds do not normally continuously issue shares for sale as open-end mutual funds do. Since the initial public offering, each Fund now trades in the secondary market. Investors wishing to buy or sell shares need to place orders through an intermediary or broker. The share price of a closed-end fund is based on the market's value. Forward-looking statements are based on information that is available on the date hereof, and neither the fund manager nor any other person affiliated with the fund manager has any duty to update any forward-looking statements. Important factors that could affect actual results to differ from these statements include, among other factors, material, negative changes to the asset class and the actual composition of the portfolio.
News Article | June 1, 2017
Hedge Connection announced today the return of its annual Global Fund Forum conference to Bermuda on October 16-18, 2017 at the Fairmont Southampton. This year’s program introduces a new faculty of speakers, panels of leading industry experts, and a variety of activities developed to educate, inspire and connect the alternative investment industry. “We take great pride in designing a truly unique experience that changes each year with brand new content and speakers that offer both industry insights and completely ‘out of the box’ topics with new formats providing an educational and memorable conference experience,” noted Hedge Connection CEO Lisa Vioni. “Our prior year attendees have praised Global Fund Forum’s exceptional program mix combined with its beautiful setting.” "Global Fund Forum is a great conference, productive on multiple levels. Lisa and the Hedge Connection team are incredibly organized and conscientious. They made sure people gained value from being there." says 2016 participant David Wertentheil, Partner of Worth Venture Partners. A number of registration options are available and include discounts for Bermudian residents and members of Hedge Connection’s Capital Club. Early Bird pricing is in effect for a limited time. Expected attendees span a wide range of asset allocators, hedge fund managers, CTAs, investment advisers, and service providers. Global Fund Forum 2017 registration is now open. About Hedge Connection Launched in 2005, Hedge Connection is a patented marketing platform for alternative investment managers as well as a robust information portal for accredited investors. Efficiently combining online introductions with live meetings, Hedge Connection has grown to become the most widely recognized, innovative and compliant marketing solution of its kind for the alternative industry. Visit http://www.hedgeconnection.com and http://twitter.com/hedgeconnection. About Global Fund Forum Global Fund Forum is produced by Hedge Connection and provides an offline setting for connecting its members and those in the alternative investment industry. Over three days, participants will gather in Bermuda to network with peers, learn from experts and effectively connect and build relationships. The Forum’s program includes expert panels, one-on-one meetings between managers and allocators, a Table Talks roundtable session, Deal Ring (a Shark Tank style event), inspirational speakers, a beach dinner party, Cigars Under the Stars, and a boat cruise. Visit the event website at http://www.globalfundforum.com and follow us on Twitter at http://twitter.com/globalfundforum.
News Article | May 10, 2017
People on Facebook can make it more fun by doing a challenge or activity if their fundraising goal is met, or challenging their friends and family to do the same. Facebook users launch their own personal fundraisers at https://www.facebook.com/fundraisers/rednosedayusa, or make a donation at facebook.com/rednosedayusa. Richard Curtis, founder of Red Nose Day, said, "The Bill & Melinda Gates Foundation has been a completely key partner of Red Nose Day and it's so wonderful to have their continued involvement this year. With the Foundation's match and Facebook's innovative fundraising tools, it's now easier than ever for people across the country to get involved and help raise money that will truly save and change children's lives." Rob Rosen, Director of Philanthropic Partnerships at the Bill & Melinda Gates Foundation, said, "Donating money should be meaningful and fun. Red Nose Day is both. We're excited to partner with Comic Relief and Facebook to reach as many people as possible to inspire them to join us in ending child poverty." Janet Scardino, CEO of Comic Relief, said, "Facebook's latest donation and fundraising tools are the ultimate way to let our fans be our fundraisers. We see Red Noses all across social, and now Facebook has made it easy to turn that into a new and personal way to give." The 2017 Red Nose Day campaign runs from now through Red Nose Day (Thursday, May 25) and everyone can get involved. Buy and wear a Red Nose, available exclusively at Walgreens and Duane Reade stores nationwide, take on a fundraising challenge and share personal stories of involvement on social media to encourage others to make a difference for children in need using #RedNoseDay and #NosesOn. On Thursday May 25, tune into NBC for a special night of Red Nose Day programming in support of the charity featuring: "Celebrity Ninja Warrior for Red Nose Day" (8 p.m. ET); "Running Wild with Bear Grylls for Red Nose Day" (9 p.m. ET), featuring Julia Roberts in Kenya; and the third annual "Red Nose Day Special" (10 p.m. ET). The three-hour primetime block will both entertain viewers and give them an opportunity to make a difference in the lives of children in need here at home and around the world. Red Nose Day is a fundraising campaign run by the non-profit organization Comic Relief Inc., a registered U.S. 501(c)(3) public charity. Red Nose Day started in the U.K., built on the foundation that the power of entertainment can drive positive change, and has raised over $1 billion globally since the campaign's founding in 1988. Red Nose Day launched in the U.S. in 2015 with a mission to raise money and awareness to end child poverty, and has raised over $60 million to date for the cause. Red Nose Day 2017 will take place on Thursday, May 25. Money raised goes to the Red Nose Day Fund, which supports programs that keep children in need safe, healthy and educated, both in America and abroad. Beneficiaries include the Boys & Girls Clubs of America; charity: water; Children's Health Fund; Feeding America; Gavi, the Vaccine Alliance; National Council of La Raza; Save the Children; and The Global Fund. Since launching in the U.S., Red Nose Day has received generous support from millions of Americans, hundreds of celebrities and many outstanding partners, including Walgreens, NBC, Mars, and the Bill & Melinda Gates Foundation. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/bill--melinda-gates-foundation-to-match-1-million-in-red-nose-day-donations-made-on-facebook-300455373.html
News Article | June 8, 2017
VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 8, 2017) - Today, Quark Venture Inc. and GF Securities announced a $US5 million investment Eloxx Pharmaceuticals through their Global Health Science Fund. This investment is part of a US$24 million financing Series C round led by Pontifax, a leading VC in the Life Sciences arena and co-founder of Eloxx Pharmaceuticals. Headquartered in Rehovot, Israel, Eloxx Pharmaceuticals is a clinical stage company developing first in class therapeutics to treat genetic diseases caused by non-sense mutations. "This investment expands our global portfolio. We are pleased to join Pontifax and other investors in this round of financing. Eloxx's lead compound, ELX-02, provides a unique opportunity to potentially be the first disease-modifying therapy to treat a set of devastating diseases, for which there are no effective treatments. We have full confidence in the company's clinical strategy and in the management team, led by CEO and co-founder Dr. Silvia Noiman," said Karimah Es Sabar, Chief Executive Office of Quark Venture and Director of GHS Fund." Eloxx's lead compound, ELX-02 has shown pharmacological, pharmacodynamic and physiological effects in several animal models of genetic disease cause by nonsense mutations including Cystic Fibrosis, Cystinosis, Duchene Muscular Dystrophy and Rett Syndrome. "We welcome Quark Venture as an investor in this round of financing. Their team bring a deep level of Life Sciences expertise. This financing enables us to initiate multiple clinical studies for EL-02. We are optimistic about advancing our lead clinical programs in cystic fibrosis and cystinosis patients carrying nonsense mutations," said Dr. Silvia Noiman, Chief Executive Officer of Eloxx Pharmaceuticals. Approximately 3 - 4 percent of newborns manifest a genetic disease or major birth defect, and about 12 percent of all mutations reported are caused by nonsense mutation. Nonsense mutations introduce premature stop codons in the reading frame of a gene. When the mutated sequence is translated into a problem, the resulting protein is incomplete and shorter than normal. Consequently, most nonsense mutations result in nonfunctional proteins. Nonsense mutations account for some of the most severe phenotypes in genetic diseases and often have devastating effects in critical target organs. ELX-02 is a translation read-through inducing drug. Read-through therapy is a treatment strategy for genetic diseases caused by nonsense mutations to increase translation and restoring activity of the mutated proteins. Quark Venture is focused on equity financing of innovative biotechnology and health sciences companies with breakthrough technology platforms and projects. The organization's approach is to establish long-term relationships with target companies, with a view to enable and strengthen management to realize the full potential and value of the technology. This approach has been previously successfully demonstrated in the energy and high-tech sectors where Quark Venture partners have invested. Quark Venture's management is supported by a scientific and commercial advisory board. For more information on Quark Venture visit www.quarkventure.com. Incorporated in September of 1991, GF Securities is a provider of comprehensive capital market services with industry-leading innovation capabilities focused on serving China's quality SMEs and affluent individuals. GF Securities is listed both on the Hong Kong (01776.HK) and Shenzhen (000776.SZ) stock exchanges with total market capitalization of approximately US$20 billion. GF Securities is an industry leader across the entire spectrum of its core business services: investment banking, wealth management, trading and institutional client services, and investment management. For more information, visit www.gf.com.cn. Global Health Science Fund was jointly established by Quark Venture Inc. and GF Securities in late 2016. Global Health Science Fund is a health sciences venture fund that invests globally in a diversified portfolio of innovative biotechnology and health sciences companies who are addressing unmet medical needs through innovations in drug development, medical devices, health IT and emerging convergent technologies. Eloxx Pharmaceuticals is a clinical stage company developing first in class therapeutics for the treatment of genetic disease caused by non-sense mutations. Eloxx was co-founded by Dr. Silvia Noiman and Pontifax, a leading VC in the Life Sciences arena. Eloxx technology is originated from the Technion - Israel Institute of Technology in Haifa, Israel, and results from research lead by Prof. Timor Baasov. For more information visit www.eloxxpharma.com.
News Article | May 9, 2017
Transformation in the European hedge fund space as a result of Brexit requires experienced fund administrators who understand a complex legal and regulatory landscape LONDON, UNITED KINGDOM--(Marketwired - May 9, 2017) - Custom House Global Fund Services, a leading independent hedge fund administration specialist, is pleased to announce that it has been selected by HFM Week as "Most Innovative Administrator -- Under $30bn in the annual HFM European Hedge Fund Services Awards. The annual European awards, presented in London at The Hurlingham Club on April 27 recognizes and rewards hedge fund service providers that have demonstrated exceptional customer service and innovative product development over the prior 12 months. Mark Hedderman, CEO of Custom House received the award on behalf of the company. "Since our office opening in London in May 2015, Custom House has seen a great deal of transformation in the hedge fund space, especially due to Brexit," said Mr. Hedderman. "As with Brexit and other previous announcements such as AIFMD, the exact impact is yet to be seen but we believe our business model is flexible and innovative enough to evolve with the implications that these changes will bring and we are prepared to assist our clients with these challenges." "We are pleased to have received this award from HFM and we will continue to provide innovative solutions to our clients without forgetting our main focus of exceptional client service," said Mr. Hedderman. "As an independent fund administrator we are a 'service led' partner to our clients with a commitment to quality and support." About Custom House Global Fund Services Custom House Global Fund Services is a leading independent hedge fund administration specialist ideally located to deliver services in Europe, Asia and the Americas. We partner with established hedge fund managers, start up managers, family offices and institutional managers, with a combination of experience, global presence and technology. Founded in 1989, Custom House grew with the alternative investment industry providing superior fund administration and investor services and today provides one of the most advanced service offerings available to fund managers. With over $20bn in AUA, Custom House provides fund administration services to more than 200 managers and 500 investment funds. The firm has offices in Beijing, Chicago, Dublin, Geneva, Guernsey, Hong Kong, London, Malta, New York, Rotterdam, Shanghai, Shenzhen, Singapore, Sofia and Sydney. For more information, visit www.customhousegroup.com.